Image Source: AsiaOne
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Revance Therapeutics, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important February 8 Deadline in Securities Class Action – RVNCGlobeNewswireJanuary 22, 2022NEW YORK, Jan. 22, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Revance Therapeutics, Inc. (NASDAQ: RVNC) between November 25, 2019 and October 11, 2021, inclusive (the “Class Period”), of the important February 8, 2022 lead plaintiff deadline. SO WHAT: If you purchased Revance securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Source: AsiaOne